FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - SubstancePolymer

273,025 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 117
R2B: 0
R3: 21,800
R4: 159,761
R4B: 43,721
R5: 32,950
R6: 2,469

By Authority

none: 191,832
hl7: 74,313
ihe: 1,327
national: 4,208
who: 1,345

By Realm

none: 185,458
au: 757
be: 606
br: 400
ca: 1,468
ch: 1,795
cl: 553
cr: 117
cz: 975
de: 2,343
dk: 1,548
ee: 255
eu: 977
fi: 87
fr: 3,309
il: 328
in: 163
it: 116
jp: 174
kr: 30
nl: 2,249
no: 128
nz: 240
pl: 258
pt: 50
se: 161
stt: 116
tw: 1,743
uk: 6
us: 22,370
uv: 44,101
vn: 108
other: 6

Start Prev Rows 223400 - 223600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.526.json	Retina Ultrasound	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.527.json	Retina visualization inadequate	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.528.json	Refusal or Noncompliance with treatment	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.529.json	Vitreous hemorrhage	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.530.json	Vitreous hemorrhage	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.536.json	Macula examination	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.539.json	Fluorescein angiography	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.541.json	Optical coherence tomography (OCT)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.542.json	Intravitreal injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.543.json	Bevacizumab injection	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.544.json	Ranibizumab injection	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.545.json	Aflibercept injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.552.json	Uveitis	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.553.json	Uveitis	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.554.json	Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.555.json	Macular edema	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.556.json	Corticosteroids for Injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.557.json	Corticosteroids for Injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.560.json	Tonometry	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.561.json	Intraocular pressure	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.571.json	Retinal Vein Occlusion Related Macular Edema	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.576.json	Vitreous hemorrhage	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.580.json	Intravitreal and Periocular Injections	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.581.json	Intravitreal and Periocular Injections	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.582.json	Corticosteroids for Injection	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.583.json	Endophthalmitis in the Right Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.584.json	Endophthalmitis in the Left Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.585.json	Panophthalmitis in the Right Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.586.json	Panophthalmitis in the Left Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.587.json	Lost to follow up	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.588.json	Uveitis	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.610.json	Scleral depressed exam	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.611.json	3 Mirror Goldmann exam	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.612.json	Scleral depressed exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.615.json	Physical Disability	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.616.json	Financial difficulty	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.617.json	Vitreous exam findings	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.619.json	Scleral depressed exam	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.629.json	Post operative follow up	active	2020-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.67.json	Breastfeeding	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.69.json	Stable and Unstable Angina	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.70.json	Ischemic Heart Disease or Related Diagnoses	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.71.json	Cerebrovascular Disease Stroke or TIA	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.73.json	Breastfeeding	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.85.json	Familial Hypercholesterolemia	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.89.json	Rhabdomyolysis	active	2017-05	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.9.json	Outpatient Encounters for Preventive Care	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.91.json	Familial Hypercholesterolemia	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.93.json	Hypercholesterolemia ICD 9	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.97.json	High Intensity Statin Therapy	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.98.json	Moderate Intensity Statin Therapy	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.50.json	HIV Lab Tests	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.51.json	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.52.json	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.53.json	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.71.json	Human Immunodeficiency Virus (HIV) Viral Load	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.10.json	ARBs (Angiotensin Receptor Blockers)	active	2024-12	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1000.json	OIA_V2_GLP1s_RxNorms	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1001.json	OIA_V2_PCSK9s_RxNorms	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1002.json	OIA_RFs_Secondary_Prevention_ICD10	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1003.json	OIA_RFs_Secondary_Prevention_SNOMED	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1004.json	OIA_RFs_Secondary_Prevention_CPT	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1005.json	OIA_RFs_Secondary_Prevention_ICD_SM_CPT	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1006.json	OIA_Asthma_COPD_Combo_Meds	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1007.json	OIA_Asthma_COPD_Combo_Meds_SABA_SAMA	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1008.json	OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1009.json	PAE_Patient_Conditions	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1012.json	PAE Conditions Short	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1016.json	OIA_TEST_VS	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1017.json	Triptan Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1018.json	NSAID Allergy NDFRT	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1019.json	Statin Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1021.json	Penicillin Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1022.json	Macrolide Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1023.json	Quinolone Allergy NDFRT	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1025.json	Beta blocker Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1026.json	ACE inhibitor Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1027.json	ARB Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1028.json	Sulfonylurea Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1030.json	DPP4i Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1031.json	GLP1RA Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1032.json	Beta blocker allergy intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1033.json	SGLT2i Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1034.json	MRA Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1036.json	Meglitinide Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1037.json	Alpha glucosidase inhibitor Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1038.json	TZD Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1041.json	Hemoglobin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1042.json	Hematocrit	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1043.json	Anemia for Erythropoesis Simulating Agents I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1044.json	Anemia for Erythropoesis Simulating Agents SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1045.json	Anemia for Erythropoesis Simulating Agents	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1046.json	AZT Meds	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1047.json	Ferritin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1048.json	Knee pain I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1049.json	Knee pain SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.105.json	conditions_heartfailure	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1050.json	Knee pain	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1051.json	Knee decreased ROM SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1052.json	Knee effusion I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1054.json	Knee effusion	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1055.json	Knee crepitus SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1056.json	OIA_Antiemetics	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1057.json	OIA_PDE5is	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1058.json	OIA_Vitamins	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1059.json	OIA_Plavix	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1061.json	OIA_Oral_Contraceptives	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1063.json	OIA_Topical_Steroids	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1064.json	OIA_Cough_Cold_Meds	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1065.json	Antiperspirant aluminum salts	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1066.json	Antiperspirant anticholinergics	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1067.json	Antieplieptic medications	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1068.json	Antidepressant medications	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1069.json	Urinary incontinence SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1070.json	Urinary incontinence I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1071.json	Urinary incontinence	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1073.json	Hemifacial spasm SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1074.json	Hemifacial spasm I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1075.json	Hemifacial spasm	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1076.json	Spasmodic dysphonia SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1077.json	Physical therapy procedure SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1078.json	Occupational therapy SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1079.json	Hyperhidrosis SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1080.json	Hyperhidrosis I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1081.json	Hyperhidrosis	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1082.json	Tic disorder I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1083.json	Tic disorder SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1084.json	Tic disorder	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1085.json	Esophageal achalasia SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1086.json	Esophageal achalasia I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1087.json	Esophageal achalasia	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1088.json	ET propanolol or primidone	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1089.json	ET topiramate alprazolam or gabapentin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.109.json	CKD stage4above I10	active	2024-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1090.json	Blephraospasm SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1091.json	Blepharospasm I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1092.json	Blepharospasm	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1093.json	Strabismus SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1094.json	Strabismus I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1095.json	Strabismus	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1096.json	Overactive bladder SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1097.json	Overactive bladder I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1098.json	Overactive bladder	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1099.json	Movement disorders SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.110.json	CKD stage4above SCT	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1100.json	Movement disorders I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1101.json	Movement disorders	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1102.json	Lateral epicondylitis SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1103.json	Lateral epicondyltisis I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1104.json	Lateral epicondylitis	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1105.json	Plantar fasciitis SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1106.json	Plantar fasciitis I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1107.json	Plantar fasciitits	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1108.json	Cardiac CT SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1109.json	Cardiac CT CPT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.111.json	CKD stage4above	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1111.json	Cardiac CT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1112.json	Cardiac MRI SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1113.json	Cardiac MRI CPT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1114.json	Cardiac MRI	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1115.json	CT Angiography of Coronary Artery SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1116.json	CT Angiography of Coronary Artery CPT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1117.json	CT Angiography of Coronary Artery	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.120.json	Diabetic ketoacidosis SCT	active	2023-07	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.121.json	Diabetic ketoacidosis	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.146.json	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.159.json	conditions_COPD I10	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.175.json	Asthma	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.184.json	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.186.json	Beta blockers GDMT for heart failure	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.188.json	medications_heart failure	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.197.json	Blood (Serum and Plasma) Potassium	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.214.json	Type 1 Diabetes Mellitus SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.238.json	MRA mineralocorticoid receptor antagonists	active	2024-10	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.244.json	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.260.json	UACR SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.263.json	Pregnancy I10	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.281.json	Statins Allergy SCT	active	2023-03	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.282.json	Statin Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.314.json	relatedconditions_hyperlipidemia I10	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.337.json	Migraine I10	active	2023-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.34.json	Blood pressure panel	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.35.json	Systolic Blood Pressure	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.367.json	Trandolapril	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.369.json	Candesartan	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.377.json	Valsartan	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.397.json	eGFR	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.412.json	Statin Moderate Intensity	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.415.json	LDL Cholesterol	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.43.json	Urinalysis	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.434.json	Insulin	active	2025-02	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.437.json	TZD Thiazolidinediones	active	2025-05	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.438.json	medications_T2DM	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.440.json	relatedconditions_T2DM SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.442.json	Blood Glucose	active	2024-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.459.json	Liver cancer	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.47.json	ACE inhibitor allergy SCT	active	2022-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.474.json	Allergy to Tdap Vaccine	active	2023-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.475.json	Allergy to Td Vaccine	active	2023-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.481.json	medications_hypertension	active	2024-12	us	hl7